Free Trial
OTCMKTS:ATTBF

Abattis Bioceuticals (ATTBF) Stock Price, News & Analysis

Abattis Bioceuticals logo

About Abattis Bioceuticals Stock (OTCMKTS:ATTBF)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
11,650 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Abattis Bioceuticals Corp. is a Canadian life sciences company focused on the development and commercialization of cannabis-, hemp- and plant-based products. Its activities have included nutraceuticals, botanical health products and other formulations intended for wellness and therapeutic applications.

The company has historically pursued opportunities across the cannabis and natural health product sectors, including product development, branding and commercialization through affiliated businesses. Its offerings have been directed primarily toward consumer health and wellness markets, although the availability of specific products and the company’s operating activities may have changed over time.

Abattis Bioceuticals has been associated with the Canadian cannabis industry and has served markets in Canada through its corporate and affiliated operations. Reliable current information about its leadership, product portfolio and ongoing business activities is limited.

AI Generated. May Contain Errors.

Receive ATTBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abattis Bioceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ATTBF Stock News Headlines

Abattis Bioceuticals Announces New CEO
Abattis Announces New Board Members
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.tc pixel
Abattis Provides Corporate Update
Abattis Bioceuticals Corp (ATTBF)
Abattis Bioceuticals Corp ATTBF
Abattis Bioceuticals Corp ATTBF Sustainability
See More Headlines

ATTBF Stock Analysis - Frequently Asked Questions

Shares of ATTBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:ATTBF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (OTCMKTS:ATTBF) was last updated on 10/4/2026 by MarketBeat.com Staff.
From Our Partners